The UK and the European Union have been locked in a dispute over the distribution of a vaccine manufactured by the British-Swedish company AstraZeneca and Oxford University, as Britain has been ramping up its sweeping inoculation programme, while the EU bloc deals with shortages and setbacks in its anti-COVID roll-out.